BioCryst Pharmaceuticals, Inc. Share Price
Stocks
BCRX
US09058V1035
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.980 USD | -2.81% |
|
-3.85% | +15.13% |
| Market Cap | 228.24Cr 198.41Cr 184.67Cr 169.55Cr 320.19Cr 22TCr 325.15Cr 2.18TCr 854.34Cr 11TCr 857.17Cr 838.34Cr 36TCr | P/E 2026 * |
-3.48x | P/E 2027 * | 14.3x |
|---|---|---|---|---|---|
| Enterprise Value | 236.33Cr 205.44Cr 191.22Cr 175.56Cr 331.54Cr 23TCr 336.67Cr 2.25TCr 884.63Cr 11TCr 887.56Cr 868.06Cr 38TCr | EV / Sales 2026 * |
3.53x | EV / Sales 2027 * | 2.89x |
| Free-Float |
94.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BioCryst Pharmaceuticals, Inc.
| 1 day | -2.81% | ||
| 1 week | -3.85% | ||
| 1 month | -10.20% | ||
| 3 months | -1.97% | ||
| 6 months | +36.47% | ||
| Current year | +15.13% |
| 1 week | 8.92 |  | 9.91 |
| 1 month | 8.92 | | 11.22 |
| Current year | 6.23 | | 11.22 |
| 1 year | 6 | | 11.22 |
| 3 years | 4.03 | | 11.31 |
| 5 years | 4.03 | | 19.99 |
| 10 years | 1.38 | | 19.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charles Gayer
CEO | Chief Executive Officer | 55 | 01/01/2026 |
Babar Ghias
DFI | Director of Finance/CFO | 47 | 07/07/2025 |
Sandeep Menon
CTO | Chief Tech/Sci/R&D Officer | 51 | 06/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Jon Stonehouse
BRD | Director/Board Member | 65 | 01/01/2007 |
Theresa Heggie
BRD | Director/Board Member | 64 | 03/12/2018 |
Charles Gayer
BRD | Director/Board Member | 55 | 01/01/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 27/02/26 | Free | Director | 1,285 | 0.0005% | ||
| 27/02/26 | Free | Director | 528 | 0.0002% | ||
| 27/02/26 | Free | Director | 642 | 0.0003% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.81% | -3.85% | +10.32% | +21.52% | 234.85Cr | |
| +2.35% | +2.74% | +33.41% | +79.20% | 5.52TCr | |
| -0.21% | -7.38% | +25.34% | +63.02% | 5.38TCr | |
| -2.44% | +1.40% | -15.74% | -16.80% | 2.35TCr | |
| -2.85% | -7.78% | -8.09% | +346.36% | 2.2TCr | |
| +2.49% | -0.92% | +20.31% | -12.15% | 1.98TCr | |
| +0.79% | -1.06% | +29.29% | -33.32% | 1.74TCr | |
| +0.58% | -5.88% | +16.30% | +540.37% | 1.47TCr | |
| -5.25% | -4.23% | +46.41% | +169.05% | 1.41TCr | |
| +3.41% | -6.61% | +163.08% | +280.43% | 1.3TCr | |
| Average | -0.39% | -3.24% | +32.06% | +143.77% | 2.36TCr | |
| Weighted average by Cap. | +0.14% | -2.74% | +28.04% | +119.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 67Cr 58Cr 54Cr 50Cr 94Cr 6.39TCr 95Cr 638.43Cr 250.56Cr 3.18TCr 251.39Cr 245.87Cr 11TCr | 73Cr 63Cr 59Cr 54Cr 101.88Cr 6.93TCr 103.46Cr 692.66Cr 271.85Cr 3.45TCr 272.75Cr 266.76Cr 12TCr |
| Net income | -64Cr -56Cr -52Cr -48Cr -90Cr -6.12TCr -91Cr -611.49Cr -239.99Cr -3.05TCr -240.79Cr -235.5Cr -10TCr | 14Cr 12Cr 11Cr 10Cr 20Cr 1.34TCr 20Cr 134.34Cr 53Cr 669.4Cr 53Cr 52Cr 2.24TCr |
| Net Debt | 8.09Cr 7.03Cr 6.55Cr 6.01Cr 11Cr 772.38Cr 12Cr 77Cr 30Cr 384.53Cr 30Cr 30Cr 1.29TCr | -18Cr -16Cr -15Cr -13Cr -25Cr -1.72TCr -26Cr -172.29Cr -68Cr -858.51Cr -68Cr -66Cr -2.88TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/26/31 | $8.980 | -2.81% | 29,28,211 |
| 30/26/30 | $9.240 | -3.04% | 23,23,022 |
| 29/26/29 | $9.530 | -2.16% | 21,94,894 |
| 28/26/28 | $9.740 | +1.67% | 28,75,375 |
| 27/26/27 | $9.580 | +2.57% | 43,10,711 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BCRX Stock
Select your edition
All financial news and data tailored to specific country editions
